In an effort to facilitate the fast growing Indian pharma industry to position itself globally, Drugs Controller General of India (DGCI) has initiated a centralised uniform system for various processes of the industry.
“Online real time system for various approvals will be fully operational within two to three,” the new DGCI DrSurendra Singh said, while inaugurating a seminar on ‘How quality pays’, organised by the Indian Drug manufacturing Association.
Singh said 60% of the delays faced by the industry was in getting test licence, export NOC and to get approval for conducting clinical trials and all these delays will be addressed by setting up a system e-governance by digitalising offices (both head office and regional offices) and having interactive portals.
DGCI office is trying to fix time frame for all the procedures of not more than eight weeks, including issuing of test licenses, NOC for export and clinical trials, in cooperation with the pharma industry.
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.